Keith Wonnacott

1.5k total citations · 2 hit papers
9 papers, 1.1k citations indexed

About

Keith Wonnacott is a scholar working on Biomedical Engineering, Surgery and Molecular Biology. According to data from OpenAlex, Keith Wonnacott has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Biomedical Engineering, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Keith Wonnacott's work include Biomedical Ethics and Regulation (3 papers), Biomedical and Engineering Education (2 papers) and CAR-T cell therapy research (2 papers). Keith Wonnacott is often cited by papers focused on Biomedical Ethics and Regulation (3 papers), Biomedical and Engineering Education (2 papers) and CAR-T cell therapy research (2 papers). Keith Wonnacott collaborates with scholars based in United States and United Kingdom. Keith Wonnacott's co-authors include James Miskin, Christopher Hunt Keir, Bruce L. Levine, Alexander M. Bailey, Steven R. Bauer, Raj K. Puri, Michael Mendicino, Robert H. Bonneau, Mark H. Lee and Jeremiah J. Wille and has published in prestigious journals such as Cell stem cell, Brain Behavior and Immunity and Tissue Engineering Part B Reviews.

In The Last Decade

Keith Wonnacott

9 papers receiving 1.1k citations

Hit Papers

Global Manufacturing of CAR T Cell Therapy 2014 2026 2018 2022 2017 2014 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Global Manufacturing of CAR T Cell Therapy
    2017 537 citations Bruce L. Levine, James Miskin et al. Molecular Therapy — Methods & Clinical Development profile →
  2. MSC-Based Product Characterization for Clinical Trials: An FDA Perspective
    2014 370 citations Michael Mendicino, Alexander M. Bailey et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Wonnacott United States 7 513 457 304 281 231 9 1.1k
Dongdong Ti China 20 801 1.6× 937 2.1× 293 1.0× 535 1.9× 250 1.1× 31 2.1k
Loïc Reppel France 17 263 0.5× 199 0.4× 145 0.5× 394 1.4× 236 1.0× 31 852
Carolyn Lutzko United States 27 403 0.8× 896 2.0× 107 0.4× 326 1.2× 410 1.8× 63 2.1k
Wouter Van’t Hof United States 23 199 0.4× 553 1.2× 120 0.4× 471 1.7× 259 1.1× 44 1.3k
Katsutsugu Umeda Japan 23 232 0.5× 995 2.2× 111 0.4× 410 1.5× 486 2.1× 108 1.8k
Deepak Bhere United States 15 355 0.7× 604 1.3× 135 0.4× 571 2.0× 191 0.8× 27 1.3k
Tatsuki Ueda Japan 11 530 1.0× 645 1.4× 142 0.5× 52 0.2× 164 0.7× 24 1.0k
Matthew E. Brown United States 14 161 0.3× 473 1.0× 212 0.7× 78 0.3× 288 1.2× 27 995
Masasuke Ohno Japan 18 429 0.8× 335 0.7× 185 0.6× 184 0.7× 64 0.3× 42 972
Christopher B. Ballas United States 14 207 0.4× 565 1.2× 117 0.4× 118 0.4× 143 0.6× 15 1.2k

Countries citing papers authored by Keith Wonnacott

Since Specialization
Citations

This map shows the geographic impact of Keith Wonnacott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Wonnacott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Wonnacott more than expected).

Fields of papers citing papers by Keith Wonnacott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Wonnacott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Wonnacott. The network helps show where Keith Wonnacott may publish in the future.

Co-authorship network of co-authors of Keith Wonnacott

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Wonnacott. A scholar is included among the top collaborators of Keith Wonnacott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Wonnacott. Keith Wonnacott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Drago, Daniela, et al.. (2021). Global regulatory progress in delivering on the promise of gene therapies for unmet medical needs. Molecular Therapy — Methods & Clinical Development. 21. 524–529. 21 indexed citations
2.
3.
Levine, Bruce L., James Miskin, Keith Wonnacott, & Christopher Hunt Keir. (2017). Global Manufacturing of CAR T Cell Therapy. Molecular Therapy — Methods & Clinical Development. 4. 92–101. 537 indexed citations breakdown →
4.
Mendicino, Michael, Alexander M. Bailey, Keith Wonnacott, Raj K. Puri, & Steven R. Bauer. (2014). MSC-Based Product Characterization for Clinical Trials: An FDA Perspective. Cell stem cell. 14(2). 141–145. 370 indexed citations breakdown →
5.
Lee, Mark H., J.W. Jones, Larysa Rudenko, et al.. (2010). Regulation of xenogeneic porcine pancreatic islets. Xenotransplantation. 17(5). 329–337. 14 indexed citations
6.
Lee, Mark H., et al.. (2009). Considerations for Tissue-Engineered and Regenerative Medicine Product Development Prior to Clinical Trials in the United States. Tissue Engineering Part B Reviews. 16(1). 41–54. 94 indexed citations
7.
8.
Wonnacott, Keith. (2005). Update on Regulatory Issues in Pancreatic Islet Transplantation. American Journal of Therapeutics. 12(6). 600–604. 12 indexed citations
9.
Wonnacott, Keith & Robert H. Bonneau. (2002). The Effects of Stress on Memory Cytotoxic T Lymphocyte-Mediated Protection against Herpes Simplex Virus Infection at Mucosal Sites. Brain Behavior and Immunity. 16(2). 104–117. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dongdong Ti Breakdown of academic impact, for papers by Loïc Reppel Breakdown of academic impact, for papers by Carolyn Lutzko Breakdown of academic impact, for papers by Wouter Van’t Hof Breakdown of academic impact, for papers by Katsutsugu Umeda Breakdown of academic impact, for papers by Deepak Bhere Breakdown of academic impact, for papers by Tatsuki Ueda Breakdown of academic impact, for papers by Matthew E. Brown Breakdown of academic impact, for papers by Masasuke Ohno Breakdown of academic impact, for papers by Christopher B. Ballas
Rankless by CCL
2026